HAMED KAMAL (Chief Medical Officer) sold 3.4% of their position (28.07K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $38.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2024ACC: 0000950170-24-011491
Officer· Chief Medical Officer
Since Sep 2022
+211.66K
Net shares
Net buyer
$38.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
239.73K acquired · 28.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+239.73K
Price / share
—
Trade value
—
% of position
41.6%
2/1/2024
576.46K→816.19K
Common Stock
Direct
Shares
−28.07K
Price / share
$1.37
Trade value
$38.46K
% of position
3.4%
2/2/2024
816.19K→788.12K
Total
Net shares
+211.66K
Net value
-$38.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2024 | A · Award | +239.73K | — | — | 41.6% | 576.46K | 816.19K |
| Common Stock Direct | 2/2/2024 | S · Sale | −28.07K | $1.37 | $38.46K | 3.4% | 816.19K | 788.12K |
| Total | +211.66K | -$38.46K | ||||||
Derivative Transactions0
No derivative transactions reported